口腔与口咽鳞状细胞癌治疗后监测增强CT解读中NI-RADS的观察者间与观察者内一致性
回顾性分析101例口腔与口咽鳞状细胞癌治疗后监测增强CT,4名放射科医师按NI-RADS对原发灶和颈部评分,观察者间一致性原发灶W=0.74、κF=0.48,颈部W=0.80、κF=0.50;有复发者一致性更高,观察者内一致性中等至几乎完美,但治疗后改变无复发者一致性受限。
要点
- NI-RADS用于口腔与口咽鳞状细胞癌治疗后监测增强CT评分,原发灶观察者间W=0.74、κF=0.48,颈部W=0.80、κF=0.50。
- 有复发患者观察者间一致性更高:原发灶W=0.96 vs 0.56、κF=0.65 vs 0.30;颈部W=0.78 vs 0.56、κF=0.41 vs 0.29。
- 观察者内一致性原发灶τB=0.67-0.82、κw=0.85-0.96,颈部τB=0.76-0.86、κw=0.89-0.95。
诊断标准与关键数值
- 观察者间一致性原发灶W=0.74、κF=0.48,颈部W=0.80、κF=0.50。
- 有复发患者原发灶观察者间W=0.96 vs 无复发0.56,κF=0.65 vs 0.30;颈部W=0.78 vs 0.56,κF=0.41 vs 0.29。
- 观察者内一致性原发灶τB=0.67-0.82、κw=0.85-0.96,颈部τB=0.76-0.86、κw=0.89-0.95。
临床应用与阅片要点
- NI-RADS用于口腔与口咽鳞状细胞癌治疗后监测增强CT的原发灶和颈部评分时,整体重复性可接受。
- 在治疗后改变且无癌症复发的患者中,NI-RADS评分一致性有限。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The Neck Imaging Reporting and Data System was introduced to assess the probability of recurrence in surveillance imaging after treatment of head and neck cancer. This study investigated inter- and intrareader agreement in interpreting contrast-enhanced CT after treatment of oral cavity and oropharyngeal squamous cell carcinoma.
MATERIALS AND METHODS: This retrospective study analyzed CT datasets of 101 patients. Four radiologists provided the Neck Imaging Reporting and Data System reports for the primary site and neck (cervical lymph nodes). The Kendall's coefficient of concordance (W), Fleiss κ (κF), the Kendall's rank correlation coefficient (τB), and weighted κ statistics (κw) were calculated to assess inter- and intrareader agreement.
RESULTS: Overall, interreader agreement was strong or moderate for both the primary site (W = 0.74, κF = 0.48) and the neck (W = 0.80, κF = 0.50), depending on the statistics applied. Interreader agreement was higher in patients with proved recurrence at the primary site (W = 0.96 versus 0.56, κF = 0.65 versus 0.30) or in the neck (W = 0.78 versus 0.56, κF = 0.41 versus 0.29). Intrareader agreement was moderate to strong or almost perfect at the primary site (range τB = 0.67-0.82, κw = 0.85-0.96) and strong or almost perfect in the neck (range τB = 0.76-0.86, κw = 0.89-0.95).
CONCLUSIONS: The Neck Imaging Reporting and Data System used for surveillance contrast-enhanced CT after treatment of oral cavity and oropharyngeal squamous cell carcinoma provides acceptable score reproducibility with limitations in patients with posttherapeutic changes but no cancer recurrence.
引用
- Elsholtz FHJ, Ro SR, Shnayien S, et al. Inter- and Intrareader Agreement of NI-RADS in the Interpretation of Surveillance Contrast-Enhanced CT after Treatment of Oral Cavity and Oropharyngeal Squamous Cell Carcinoma. AJNR Am J Neuroradiol. 2020. PMID: 32327436. doi:10.3174/ajnr.A6529
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。